Savile, Christopher Kenneth

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 8% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -27%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Savile, Christopher Kenneth's trades of Willow Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-18 2024-07-18
B Purchase
50,514 -22.9%
250.43
CA$1,832,487 		50,514 -22.9% 250.43 CA$1,832,487
2023-11-30 2023-11-29
B Purchase
67,365 -9.5%
206.41
CA$2,644,538 		67,365 -9.5% 206.41 CA$2,644,538
2023-03-31 2023-03-30
S Sale
90,510 +36.2%
166.59
CA$1,414,584 		90,510 +36.2% 166.59 CA$1,414,584
2022-11-10 2022-11-10
B Purchase
50,000 +8.3%
0.14
CA$6,750 		50,000 +8.3% 0.14 CA$6,750
2022-09-20 2022-09-20
B Purchase
40,000 +7.1%
0.12
CA$4,900 		40,000 +7.1% 0.12 CA$4,900
2022-09-13 2022-09-09
B Purchase
30,000 +6.7%
0.16
CA$4,650 		30,000 +6.7% 0.16 CA$4,650